InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.30
(
0.44%
)
Bitcoin
57,503.79
(
-4.42%
)
Post# of 27550
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Katfish

Send PM Follow Ignore
Followers 78
Posts 24632
Boards Moderated 1
Alias Born 09/08/2000

Katfish

Member Level

Re: None

Tuesday, 03/12/2024 8:12:30 AM

Tuesday, March 12, 2024 8:12:30 AM

Post# of 27550
RGLS - 1.38 Pre-market at 2.18/2.19

Regulus Therapeutics Announces Positive Topline Data from the Second Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up